4507
Shionogi & Co.,Ltd.
塩野義製薬
- Industry
- Pharmaceutical
- Market
- Prime
- Accounting standards
- IFRS
- Consolidation basis
- Consolidated
Notes
- Stock adjustmentsOct 1, 2024 Stock split 1 share → 3 shares
Key metrics
Revenue(million JPY)
Mar 2022
335,138
Mar 2023
426,684
Mar 2024
410,073
Mar 2025
438,268
Mar 2026
499,677
Operating profit(million JPY)
Mar 2022
110,312
Mar 2023
149,003
Mar 2024
153,310
Mar 2025
156,603
Mar 2026
166,725
Operating profit margin(%)
Mar 2022
32.92
Mar 2023
34.92
Mar 2024
37.39
Mar 2025
35.73
Mar 2026
33.37
Profit before tax(million JPY)
Mar 2022
126,268
Mar 2023
220,332
Mar 2024
198,283
Mar 2025
200,750
Mar 2026
238,916
Profit(million JPY)
Mar 2022
114,185
Mar 2023
184,965
Mar 2024
162,030
Mar 2025
170,435
Mar 2026
205,159
Total assets(million JPY)
Mar 2022
1,150,601
Mar 2023
1,311,800
Mar 2024
1,416,918
Mar 2025
1,535,349
Mar 2026
2,576,870
Cash and cash equivalents(million JPY)
Mar 2022
254,420
Mar 2023
309,224
Mar 2024
358,090
Mar 2025
374,795
Mar 2026
711,397
Cash flows from operating activities(million JPY)
Mar 2022
102,068
Mar 2023
177,867
Mar 2024
154,284
Mar 2025
195,460
Mar 2026
213,572
Cash flows from investing activities(million JPY)
Mar 2022
-96,204
Mar 2023
-48,292
Mar 2024
5,922
Mar 2025
-116,080
Mar 2026
-506,137
Cash flows from financing activities(million JPY)
Mar 2022
-36,615
Mar 2023
-84,123
Mar 2024
-126,853
Mar 2025
-64,908
Mar 2026
599,321
Return on equity(%)
Mar 2022
12.5
Mar 2023
17.8
Mar 2024
13.9
Mar 2025
13.1
Mar 2026
13.5
Equity ratio(%)
Mar 2022
84.8
Mar 2023
83.9
Mar 2024
87.2
Mar 2025
88.7
Mar 2026
65.4
Earnings per share(JPY per share)
Mar 2022
126.25
Mar 2023
207.1033
Mar 2024
186.17
Mar 2025
200.36
Mar 2026
241.11
Net assets per share(JPY per share)
Mar 2022
1,078.7367
Mar 2023
1,245.92
Mar 2024
1,452.2167
Mar 2025
1,600.68
Mar 2026
1,980.14
Dividend per share(JPY per share)
Mar 2022
38.3333
Mar 2023
45
Mar 2024
53.3333
Mar 2025
61.33
Mar 2026
71
Payout ratio(%)
Mar 2022
30.36
Mar 2023
21.73
Mar 2024
28.65
Mar 2025
30.61
Mar 2026
29.45
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.